Medical Second Opinion Market by Service Providers - 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Medical second opinion market
Medical Second Opinion Market: By Disease (Cancer, Cardiac Disorders, Diabetes, Injuries and Others); By Service Providers (Hospitals, Online and Offline Medical Second Opinion Providers and Health Insurance Players) & By Geography-Forecast(2015-2020)
Report Code : HCR 0024
Published: 12 January, 2015   No. of pages: 174

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

This report gives an in-depth segmentation of the market By Type of Disorders and Service Providers. It is also segmented by End-Use Verticals and key Geographic Regions like Americas, Europe and Asia-pacific. The market is also segregated on the basis of Service Providers such as Hospitals, Medical Second Opinion companies and Health Insurance companies.

The need for a medical second opinion is high in the case of chronic ailments such as Neurological disorders, Ocular disorders, pulmonary disorders, and Nephrological disorders. Patients diagnosed with cancer are the major customers for second opinion service providers, owing to the high cost of treatment and complexity of the treatment procedures.

Medical Second Opinion Market

Medical Second Opinion market is analyzed on a global level. Americas will lead the market during the forecast period till 2021 due to high adoption rate by the users, high incidence rate for chronic diseases such as Diabetes and Cancer, Medicare coverage and favorable market environment for startup growth. Asia-Pacific has witnessed the highest growth rate in the light of improving healthcare infrastructure and increasing awareness about the concept of Medical Second Opinion. The increasing instances of diagnostic failure coupled with huge investments in mobile and e-healthcare systems will propel the market growth.

The major players documented in this report are:
  • Johns Hopkins,
  • Cleveland Clinic,
  • HCA Hospitals,
  • Best Doctors Inc.
  • Penn Medicine.

The methodology for estimating the Medical Second Opinion market involved the conventional utilization of medical second opinion service supply and demand in the industries. There are several segmentations involved in the report based on disorders and service providers. Research interviews were conducted with senior executives and/or managers of leading hospitals such as Cleveland Clinic and Johns Hopkins Medicine. These Key Opinion Leaders (KOLs) were then provided a questionnaire to gather quantitative and qualitative inputs on their operations, performance, strategies and views on the overall market, including key developments and technology trends.
1. Global Medical Second Opinion Market Overview
2. Executive Summary
3. Global Medical Second Opinion Market Landscape
   3.1. Market share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End-User Profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financial Analysis
4. Medical Second Opinion - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Medical Second Opinion Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle Analysis
   5.5. Suppliers & Distributors
6. Medical Second Opinion Market – By Disorders
   6.1. Introduction
   6.2. Cancer
   6.3. Diabetes
   6.4. Cardiac disorders
   6.5. Neurological disorders
   6.6. Ocular disorders
   6.7. Pulmonary disorders
   6.8. Nephrological disorders
   6.9. Allergies
   6.10. Injuries
   6.11. Others
7. Medical Second Opinion Market – By Service Providers
   7.1. Introduction
   7.2. Hospitals
   7.3. Medical Second Opinion Providing Companies
   7.4. Health Insurance Companies
   7.5. Online Services
   7.6. Others
8. Medical Second Opinion Market – By Geography
   8.1. Introduction
   8.2. Americas
      8.2.1. U.S.
      8.2.2. Canada
      8.2.3. Brazil
      8.2.4. Argentina
      8.2.5. Others
      8.2.6. Europe
      8.2.7. U.K.
      8.2.8. Germany
      8.2.9. France
      8.2.10. Spain
      8.2.11. Italy
      8.2.12. Others
   8.3. APAC
      8.3.1. China
      8.3.2. Japan
      8.3.3. India
      8.3.4. Australia
      8.3.5. Others
   8.4. RoW
      8.4.1. Middle East
      8.4.2. Africa
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, Partnerships & JVs
10. Investment Opportunities
11. Company Profiles
   11.1. Advance Medical
   11.2. Mediguide America
   11.3. Johns Hopkins USA
   11.4. Best Doctors
   11.5. Cleveland Clinic
   11.6. Bupa Global 
   11.7. WorldCare International Inc.
   11.8. Grand Rounds
   11.9. XMRI.com
   11.10. HCA Hospitals
   11.11. Penn Medicine
   11.12. Cynergy Care
   11.13. MediAngels.com
   11.14. Medical Second Opinion Pvt. Ltd.
   11.15. UC San Diego Health System
   11.16. AXA PPP Healthcare
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
List of Tables:

Table 1. Global Medical Second Opinion Market Revenue, By Disorders, 2014 - 2020 ($Million)
Table 2. Numbe Ro People Suffering From Blindness And Vision Impairment Include
Table 3. Global Market for Medical Second Opinion, Revenue By Service Provider, 2014 - 2020 ($Million)
Table 4. Global Market for Medical Second Opinion, Revenue By Region, 2014 - 2020 ($Million)
Table 5. Americas Market for Medical Second Opinion, Revenue By Disorders, 2014 - 2020 ($Million)
Table 6. Americas Market for Medical Second Opinion, Revenue By Service Provider, 2014 - 2020 ($Million)
Table 7. Americas Market for Medical Second Opinion, Revenue By Country, 2014 - 2020 ($Million)
Table 8. Europe Market for Medical Second Opinion, Revenue By Disorders, 2014 - 2020 ($Million)
Table 9. Europe Market for Medical Second Opinion, Revenue By Service Provider, 2014 - 2020 ($Million)
Table 10. Europe Medical Second Opinion Market Revenue, By Country, 2014 - 2020 ($Million)
Table 11. APAC Market for Medical Second Opinion, Revenue By Disorders, 2014 - 2020 ($Million)
Table 12. APAC Market for Medical Second Opinion, Revenue By Service Provider, 2014 - 2020 ($Million)
Table 13. APAC Market for Medical Second Opinion, Revenue By Country, 2014 - 2020 ($Million)
Table 14. Row Market for Medical Second Opinion, Revenue By Disorders, 2014 - 2020 ($Million)
Table 15. Row Market for Medical Second Opinion, Revenue By Service Provider, 2014 - 2020 ($Million)
Table 16. APAC Medical Second Opinion Market Revenue, By Country, 2014 - 2020 ($Million)

 
List of Figures :

Figure 1. Global Medical Second Opinion Market, By Disorders
Figure 2. Global Medical Second Opinion Market, By Service Providers
Figure 3. Market for Medical Second Opinion, Revenue 2014-2020 ($Billion)
Figure 4. Market for Medical Second Opinion, Revenue By Geographic Region (%)
Figure 5. Global Medical Second Opinion Market,Value Chain Analysis
Figure 6. Global Medical Second Opinion Market, Product/Market Lifecycle Analysis
Figure 7. Global Medical Second Opinion Market, Product/Market Lifecycle Analysis, Developing Nations
Figure 8. Financial Performance, 2010-14 ($Billion)
Figure 9. Financial Performance, 2010-2014 ($Million)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports